Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Final Analysis of the Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab for DLBCL: JCOG0601

Blood (2023) 142 (Supplement 1): 1724.

https://doi.org/10.1182/blood-2023-178551

Published: 2023

Journal Articles

Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab (RW-CHOP) for Previously Untreated DLBCL: JCOG0601

Blood (2018) 132 (Supplement 1): 4194.

https://doi.org/10.1182/blood-2018-99-110201

Published: 2018

Journal Articles

Randomized Phase II Study of R-CHOP-14 Versus R-CHOP-14 Followed By Chaser As Induction Therapy for High-Dose Chemotherapy (HDT), LEED, and Autologous Stem-Cell Transplantation (ASCT) in Poor-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Japan Clinical Oncology Group (JCOG) Study (JCOG0908)

Blood (2017) 130 (Supplement 1): 4127.

https://doi.org/10.1182/blood.V130.Suppl_1.4127.4127

Published: 2017

Journal Articles

Function of Integrin αIIbβ3 in Essential Thrombocythemia with Calreticulin Mutation

Jun Yamanouchi, MD PhD, Takaaki Hato, MDPhD, Etsuko Matsubara, MDPhD, Taichi Azuma, MDPhD, Hiroshi Fujiwara, MD PhD, Yoshihiro Yakushijin, MDPhD, Masaki Yasukawa, MD PhD

Blood (2015) 126 (23): 4079.

https://doi.org/10.1182/blood.V126.23.4079.4079

Published: 2015

Journal Articles

Activation Status of Integrin αIIbβ3 in Essential Thrombocythemia with Calreticulin Mutation

Jun Yamanouchi, MD PhD, Takaaki Hato, MDPhD, Etsuko Matsubara, MDPhD, Taichi Azuma, MDPhD, Hideyuki Nakanishi, MD, Hiroshi Fujiwara, MD PhD, Yoshihiro Yakushijin, MDPhD, Masaki Yasukawa, MD PhD

Blood (2014) 124 (21): 4571.

https://doi.org/10.1182/blood.V124.21.4571.4571

Published: 2014

Journal Articles

Ki-67 Is a Strong Predictor for Central Nervous System Relapse in Patients with Mantle Cell Lymphoma (MCL)

Dai Chihara, MD PhD, Naoko Asano, MD PhD, Ohmachi Ken, Momoko Nishikori, MD, PhD, Masataka Okamoto, Masashi Sawa, Rika Sakai, MD PhD, Yasushi Okoshi, MD PhD, Norifumi Tsukamoto, MD PhD, Yoshihiro Yakushijin, MDPhD, Shigeo Nakamura, MD PhD, Tomohiro Kinoshita, Michinori Ogura, MD PhD, Ritsuro Suzuki, MD PhD

Blood (2014) 124 (21): 1660.

https://doi.org/10.1182/blood.V124.21.1660.1660

Published: 2014

Journal Articles

A Glycan Wedge Between βTD and βI Domains Activates Integrin αIIbβ3,

Jun Yamanouchi, MD, PhD, Takaaki Hato, MD, PhD, Hiroshi Fujiwara, MD, PhD, Yoshihiro Yakushijin, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2011) 118 (21): 3259.

https://doi.org/10.1182/blood.V118.21.3259.3259

Published: 2011

Journal Articles

The Role of Activation-Induced Cytidine Deaminase (AID/AICDA) in the Progression of Follicular Lymphoma

Hisaharu Shikata, Yoshihiro Yakushijin, MD, PhD, Natsuki Matsushita, Akira Sakai, MD, PhD, Atsuro Sugita, Naoya Nakamura, MD, PhD, Jun Yamanouchi, MD, PhD, Taichi Azuma, Takaaki Hato, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2011) 118 (21): 5234.

https://doi.org/10.1182/blood.V118.21.5234.5234

Published: 2011

Journal Articles

Aurora-A kinase: a novel target of cellular immunotherapy for leukemia

Toshiki Ochi, Hiroshi Fujiwara, Koichiro Suemori, Taichi Azuma, Yoshihiro Yakushijin, Takaaki Hato, Kiyotaka Kuzushima, Masaki Yasukawa

Blood (2009) 113 (1): 66–74.

https://doi.org/10.1182/blood-2008-06-164889

Published: 2009

Includes: Supplemental data

Journal Articles

Clinical Significance of CD21 Co-Expressed with LFA-1 in Non-Hodgkin’s B-Cell Lymphoma.

Kazushi Tanimoto, MD, Yoshihiro Yakushijin, MD, PhD, Hiroshi Fujiwara, MD, PhD, Masaki Otsuka, MD, PhD, Koichi Ohshima, MD, PhD, Atsuro Sugita, MD, PhD, Akira Sakai, MD, PhD, Takaaki Hato, MD, PhD, Hitoshi Hasegawa, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2008) 112 (11): 1781.

https://doi.org/10.1182/blood.V112.11.1781.1781

Published: 2008

Journal Articles

Integrin β3 Membrane-Proximal and -Distal Residues Cooperatively Regulate Talin-Mediated αIIbβ3 Activation.

Jun Yamanouchi, Takaaki Hato, MD, Hiroshi Fujiwara, MD, PhD, Yoshihiro Yakushijin, MD, PhD, Masaki Yasukawa

Blood (2008) 112 (11): 1848.

https://doi.org/10.1182/blood.V112.11.1848.1848

Published: 2008

Journal Articles

C-Terminal Defect of CD20 on T-Cell Leukemia/Lymphoma Cells: Implications for Resistance to Rituximab

Hiroyuki Takamatsu, MD, PhD, Yoshihiro Yakushijin, MD, PhD, Koji Miyazaki, MD, PhD, Akiyoshi Takami, MD, PhD, Masahide Yamazaki, MD, PhD, Hirokazu Okumura, MD, PhD, Shinji Nakao, MD, PhD

Blood (2008) 112 (11): 5267.

https://doi.org/10.1182/blood.V112.11.5267.5267

Published: 2008

Journal Articles

Activation of Integrin αIIbβ3 through Toll-Like Receptors in Platelets.

Jun Yamanouchi, MD, PhD, Jun An, MD, Hiroshi Fujiwara, MD, PhD, Yoshihiro Yakushijin, MD, PhD, Takaaki Hato, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2007) 110 (11): 3892.

https://doi.org/10.1182/blood.V110.11.3892.3892

Published: 2007

Journal Articles

Absence of Chlamydial Infection in Japanese Patients with Ocular Adnexal MALT Lymphoma.

Yoshihiro Yakushijin, MD, PhD, Toshio Kodama, MD, PhD, Ikue Takaoka, Kazushi Tanimoto, MD, Hiroko Bessho, PhD, Jun Yamanouchi, MD, PhD, Taichi Azuma, MD, PhD, Hiroshi Narumi, MD, PhD, Takaaki Hato, MD, PhD, Hitoshi Hasegawa, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2006) 108 (11): 4626.

https://doi.org/10.1182/blood.V108.11.4626.4626

Published: 2006

Journal Articles

Identification of Critical Residues for Affinity Regulation of β3 Integrins in the β6-α7 Loop of the I-Like Domain.

Jun Yamanouchi, MD, Takaaki Hato, MD, Yoshihiro Yakushijin, MD, Ikuya Sakai, MD, Masaki Yasukawa, MD

Blood (2006) 108 (11): 1526.

https://doi.org/10.1182/blood.V108.11.1526.1526

Published: 2006

Journal Articles

Direct recognition and lysis of leukemia cells by WT1-specific CD4 + T lymphocytes in an HLA class II-restricted manner

Yun Guo, Hironari Niiya, Taichi Azuma, Naoyuki Uchida, Yoshihiro Yakushijin, Ikuya Sakai, Takaaki Hato, Masuhiro Takahashi, Satoru Senju, Yasuharu Nishimura, Masaki Yasukawa

Blood (2005) 106 (4): 1415–1418.

https://doi.org/10.1182/blood-2005-01-0413

Published: 2005

Journal Articles

Extreme Effectiveness of Operative Resection with or without Radiotherapy as a First Line Treatment for Localized Orbital Malt Lymphoma.

Yoshihiro Yakushijin, MD, PhD, Toshio Kodama, MD, PhD, Ikue Takaoka, Masaki Otsuka, MD, Takaaki Hato, MD, PhD, Masaki Yasukawa, MD, PhD, Shigeru Fujita, MD, PhD

Blood (2004) 104 (11): 4611.

https://doi.org/10.1182/blood.V104.11.4611.4611

Published: 2004

Journal Articles

Generation of Tumor-Specific CD8 + Cytotoxic T Lymphocytes and CD4 + Th1 Helper T Cells by Transfer of T-Cell Receptor Genes Isolated from a WT1-Specific CD8 + Cytotoxic T-Lymphocyte Clone.

Masaki Yasukawa, M.D., Ph.D., Hironari Niiya, M.D., Taichi Azuma, M.D., Naoyuki Uchida, M.D., Ph.D., Yoshihiro Yakushijin, M.D., Ph.D., Ikuya Sakai, M.D., Ph.D., Takaaki Hato, M.D., Ph.D., Shigeru Fujita, M.D., Ph.D., Takemasa Tsuji, Ph.D., Takashi Nishimura, M.D., Ph.D.

Blood (2004) 104 (11): 2523.

https://doi.org/10.1182/blood.V104.11.2523.2523

Published: 2004

Journal Articles

The Expression of the CD21 Antigen in Non-Hodgkin’s Lymphoma Is Involved in LFA-1 Expression and Tumor Survival.

Masaki Otsuka, MD, Yoshihiro Yakushijin, MD, PhD, Makoto Hamada, MD, PhD, Takaaki Hato, MD, PhD, Masaki Yasukawa, MD, PhD, Sigeru Fujita, MD, PhD

Blood (2004) 104 (11): 2285.

https://doi.org/10.1182/blood.V104.11.2285.2285

Published: 2004

Journal Articles

Differential Regulation of Perforin Expression in CD4 + and CD8 + Cytotoxic T Lymphocytes.

Hironari Niiya, M.D., Jin Lei, M.D., Ikuya Sakai, M.D., Ph.D., Taichi Azuma, M.D., Naoyuki Uchida, M.D., Ph.D., Yoshihiro Yakushijin, M.D., Ph.D., Takaaki Hato, M.D., Ph.D., Shigeru Fujita, M.D., Ph.D., Masaki Yasukawa, M.D., Ph.D.

Blood (2004) 104 (11): 3848.

https://doi.org/10.1182/blood.V104.11.3848.3848

Published: 2004

NARROW

Final Analysis of the Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab for DLBCL: JCOG0601

Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab (RW-CHOP) for Previously Untreated DLBCL: JCOG0601

Randomized Phase II Study of R-CHOP-14 Versus R-CHOP-14 Followed By Chaser As Induction Therapy for High-Dose Chemotherapy (HDT), LEED, and Autologous Stem-Cell Transplantation (ASCT) in Poor-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Japan Clinical Oncology Group (JCOG) Study (JCOG0908)

Function of Integrin αIIbβ3 in Essential Thrombocythemia with Calreticulin Mutation

Activation Status of Integrin αIIbβ3 in Essential Thrombocythemia with Calreticulin Mutation

Ki-67 Is a Strong Predictor for Central Nervous System Relapse in Patients with Mantle Cell Lymphoma (MCL)

A Glycan Wedge Between βTD and βI Domains Activates Integrin αIIbβ3,

The Role of Activation-Induced Cytidine Deaminase (AID/AICDA) in the Progression of Follicular Lymphoma

Aurora-A kinase: a novel target of cellular immunotherapy for leukemia

Clinical Significance of CD21 Co-Expressed with LFA-1 in Non-Hodgkin’s B-Cell Lymphoma.

Integrin β3 Membrane-Proximal and -Distal Residues Cooperatively Regulate Talin-Mediated αIIbβ3 Activation.

C-Terminal Defect of CD20 on T-Cell Leukemia/Lymphoma Cells: Implications for Resistance to Rituximab

Activation of Integrin αIIbβ3 through Toll-Like Receptors in Platelets.

Absence of Chlamydial Infection in Japanese Patients with Ocular Adnexal MALT Lymphoma.

Identification of Critical Residues for Affinity Regulation of β3 Integrins in the β6-α7 Loop of the I-Like Domain.

Direct recognition and lysis of leukemia cells by WT1-specific CD4 + T lymphocytes in an HLA class II-restricted manner

Extreme Effectiveness of Operative Resection with or without Radiotherapy as a First Line Treatment for Localized Orbital Malt Lymphoma.

Generation of Tumor-Specific CD8 + Cytotoxic T Lymphocytes and CD4 + Th1 Helper T Cells by Transfer of T-Cell Receptor Genes Isolated from a WT1-Specific CD8 + Cytotoxic T-Lymphocyte Clone.

The Expression of the CD21 Antigen in Non-Hodgkin’s Lymphoma Is Involved in LFA-1 Expression and Tumor Survival.

Differential Regulation of Perforin Expression in CD4 + and CD8 + Cytotoxic T Lymphocytes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only